These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Evaluation of the magnitude of the bronchodilator response in children and adolescents with asthma.
    Author: Bussamra MH, Cukier A, Stelmach R, Rodrigues JC.
    Journal: Chest; 2005 Feb; 127(2):530-5. PubMed ID: 15705992.
    Abstract:
    STUDY OBJECTIVE: Bronchodilator response criteria have been determined in adults; however, data applicable to children and adolescents are scarce. We measured pulmonary function in asthmatic patients to determine the bronchodilator response. DESIGN: A blind study. SETTING: Outpatient clinic of Pneumology Unit, Instituto da Crianca and Center of Asthma Care and Research, University Hospital, University of Sao Paulo Medical School. PATIENTS: Sixty patients aged 6 to 20 years (median, 12 years). INTERVENTIONS: Spirometry and plethysmography were performed before and after blind placebo and bronchodilator inhalation (400 mug salbutamol by metered-dose inhaler). MEASUREMENTS AND RESULTS: Approximately 90% of the patients had mild-to-moderate persistent asthma. The mean FEV(1) at baseline was 79.6% of the predicted value. Distribution of variations of the different pulmonary function parameters was analyzed after placebo inhalation. The 95th percentile was adopted as a criterion for a significant bronchodilator response. After the bronchodilator test, the patients were classified based on criteria derived from the placebo inhalation and the American Thoracic Society guidelines. Parameters established as cutoff values were 265 mL, 14.2% and 10% FEV(1) expressed as absolute volume, percentage compared with that at baseline and percentage of the predicted value, respectively, and 55% specific airway conductance (sGaw) expressed as a percentage compared with that at baseline. Based on the spirometric data, 37 patients (61%) had reversibility of obstruction, while 48 patients (80%) were classified as responders based on the analysis of variations in sGaw. The classifications based on variations in FEV(1) expressed as absolute volume and percentage of the predicted value showed a substantial correlation with the international classification. CONCLUSIONS: The cutoff values established for the assessment of the bronchodilator response in the present population agree with those reported in the literature. sGaw was the most sensitive parameter for the identification of changes in airway caliber.
    [Abstract] [Full Text] [Related] [New Search]